Загрузка...
No evidence for alteration in early secondary mineralization by either alendronate, teriparatide or combination of both in transiliac bone biopsy samples from postmenopausal osteoporotic patients
The influence of treatment with alendronate (ALN), teriparatide (TPTD) or concurrent treatment with both on the human bone matrix mineralization has not yet been fully elucidated. For this purpose we analyzed quadruple fluorochrome labelled transiliac bone biopsy samples (n = 66) from postmenopausal...
Сохранить в:
| Опубликовано в: : | Bone Rep |
|---|---|
| Главные авторы: | , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Elsevier
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7090359/ https://ncbi.nlm.nih.gov/pubmed/32215284 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bonr.2020.100253 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|